Respighi BidCo announced an increase in the consideration for its offer for Recordati to €53.00 per share and extended the acceptance period to 23 October 2026.
Healthcare & Life Sciences · Italy
Previously: Recordati reported first-half 2026 net-revenue growth of 6.6%, EBITDA growth of 8.8%, and adjusted-net-income growth of 6.7%.
Read maintained: 2026-10-26